DOCS eps in a glimpse
Analyst Rating Consensus
40
Ratings
DOCS Price Target
Highest Price Target
$84.00
44.18% Upside
)Mean Price Target
$44.61
-23.43% Downside
)Lowest Price Target
$19.00
-67.39% Downside
)DOCS Recent Analyst Ratings
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
DOCS Earnings History
Frequently Asked Questions
Brokerage firms have given DOCS stock an average recommendation of Hold. 40 analysts have given their ratings to DOCS out of which 7 analysts have given strong buy call, 10 analysts have given buy call, 20 analysts rate it hold, 3 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $44.61 gives the stock implied upside of roughly -23.43% over the next year or so.
Analysts suggest DOCS's stock price would rise to a high of $84.00.
Within the next 12 months, analysts predict the DOCS stock price could move to $19.00.
DOCS stock has an average analyst estimate of $44.61.
DOCS shares are currently trading -23.43% below this price target.
Its quarterly earnings per share (EPS) came in at $0.30 versus consensus estimates of $0.25, and above the comparable year-ago quarter’s EPS of $0.29.
DOCS's forecasts by analysts estimating quarterly EPS at $0.24 and $5.83 for the whole year.
The analysts have projected 15.32% EPS growth for DOCS in the next five years, compared to growth rates of 193.38% in the past five years.